COPD elicits remodeling of the diaphragm and vastus lateralis muscles in humans

Journal of Applied Physiology

Volumn 114, Issue 9, 2013, Pages 1235-1245

  Levine, Sanford ^a   Bashir, Muhammad H ^a   Clanton, Thomas L ^b   Powers, Scott K ^b   Singhal, Sunil ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Chronic obstructive pulmonary disease; Diaphragm; Fast twitch fiber; Fiber type transformation; Slow twitch fiber; Vastus lateralis

Indexed keywords

SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

BIOLOGICAL MODEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAPHRAGM; FAST MUSCLE FIBER; FAST-TWITCH FIBER; FIBER TYPE TRANSFORMATION; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; QUADRICEPS FEMORIS MUSCLE; REVIEW; SARCOMERE; SLOW MUSCLE FIBER; SLOW-TWITCH FIBER; VASTUS LATERALIS;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; DIAPHRAGM; FAST-TWITCH FIBER; FIBER TYPE TRANSFORMATION; SLOW-TWITCH FIBER; VASTUS LATERALIS;

DIAPHRAGM; HUMANS; MODELS, BIOLOGICAL; MUSCLE FIBERS, FAST-TWITCH; MUSCLE FIBERS, SLOW-TWITCH; OXIDATIVE STRESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; SARCOMERES; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 84878523880     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.01121.2012     Document Type: Review

References (80)

1. Alexopoulou C, Mitrouska I, Arvanitis D, Tzanakis N, Chalkiadakis G, Melissas J, Zervou M, Siafakas N. Vascular-specific growth factor mRNA levels in the human diaphragm. Respiration 72:636-641, 2005. (Pubitemid 41798144)
2. Arora NS, Rochester DF. COPD and human diaphragm muscle dimensions. Chest 91:719-724, 1987. (Pubitemid 17069171)
3. Barreiro E, De La Puente B, Minguella J, Corominas JM, Serrano S, Hussain SN, Gea J. Oxidative stress and respiratory muscle dysfunction in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171:1116-1124, 2005. (Pubitemid 40663723)
4. Barreiro E, Peinado VI, Galdiz JB, Ferrer E, Marin-Corral J, Sanchez F, Gea J, Barbera JA; ENIGMA in COPD Project. Cigarette smoke-induced oxidative stress: a role in chronic obstructive pulmonary disease skeletal muscle dysfunction. Am J Respir Crit Care Med 182:477-488, 2010.
5. Barreiro E, Rabinovich R, Marin-Corral J, Barbera JA, Gea J, Roca J. Chronic endurance exercise induces quadriceps nitrosative stress in patients with severe COPD. Thorax 64:13-19, 2009.
6. Brooke MH, Kaiser KK. Three "myosin adenosine triphosphatase" systems: the nature of their pH lability and sulfhydryl dependence. J Histochem Cytochem 18:670-672, 1970.
7. Calabria E, Ciciliot S, Moretti I, Garcia M, Picard A, Dyar KA, Pallafacchina G, Tothova J, Schiaffino S, Murgia M. NFAT isoforms control activity-dependent muscle fiber type specification. Proc Natl Acad Sci USA 106:13335-13340, 2009.
8. Caron MA, Debigare R, Dekhuijzen PN, Maltais F. Comparative assessment of the quadriceps and the diaphragm in patients with COPD. J Appl Physiol 107:952-961, 2009.
9. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel-Duby R, Williams RS. A calcineurindependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev 12:2499-2509, 1998. (Pubitemid 28406953)
10. Clanton TL, Levine S. Respiratory muscle fiber remodeling in chronic hyperinflation: dysfunction or adaptation? J Appl Physiol 107:324-335, 2009.
11. Farkas GA, Roussos C. Adaptability of the hamster diaphragm to exercise and/or emphysema. J Appl Physiol 53:1263-1272, 1982. (Pubitemid 13220615)
12. Farkas GA, Roussos C. Diaphragm in emphysematous hamsters: sarcomere adaptability. J Appl Physiol 54:1635-1640, 1983. (Pubitemid 13060003)
13. Fermoselle C, Rabinovich R, Ausin P, Puig-Vilanova E, Coronell C, Sanchez F, Roca J, Gea J, Barreiro E. Does oxidative stress modulate limb muscle atrophy in severe copd patients? Eur Respir J 40:851-862, 2012.
14. Gea J, Casadevall C, Pascual S, Orozco-Levi M, Barreiro E. Respiratory diseases and muscle dysfunction. Expert Rev Respir Med 6:75-90, 2012.
15. Gea J, Orozco-Levi M, Barreiro E, Ferrer A, Broquetas J. Structural and functional changes in the skeletal muscles of COPD patients: the "compartments" theory. Monaldi Arch Chest Dis 56:214-224, 2001. (Pubitemid 32951962)
16. Gea JG, Pasto M, Carmona MA, Orozco-Levi M, Palomeque J, Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 17:939-945, 2001. (Pubitemid 32600343)
17. Geiger PC, Cody MJ, Macken RL, Sieck GC. Maximum specific force depends on myosin heavy chain content in rat diaphragm muscle fibers. J Appl Physiol 89:695-703, 2000. (Pubitemid 30637120)
18. Glass DJ. Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 13:225-229, 2010.
19. Gosker HR, Zeegers MP, Wouters EF, Schols AM. Muscle fibre type shifting in the vastus lateralis of patients with COPD is associated with disease severity: a systematic review and meta-analysis. Thorax 62:944-949, 2007. (Pubitemid 350084491)
20. Gouzi F, Prefaut C, Abdellaoui A, Roudier E, De Rigal P, Molinari N, Laoudj-Chenivesse D, Mercier J, Birot O, Hayot M. Blunted muscle angiogenic training-response in copd patients versus sedentary controls. Eur Respir J; doi:10.1183/09031936.00053512.
21. Green HJ, Bombardier E, Burnett M, Iqbal S, D'Arsigny CL, O'Donnell DE, Ouyang J, Webb KA. Organization of metabolic pathways in vastus lateralis of patients with chronic obstructive pulmonary disease. Am J Physiol Regul Integr Comp Physiol 295:R935-R941, 2008.
22. Jackman RW, Cornwell EW, Wu CL, Kandarian SC. NF-B signaling pathway and transcriptional regulation in skeletal muscle atrophy. Exp Physiol; doi:10.1113/expphysiol.2011.063321.
23. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 8:1865-1879, 2006. (Pubitemid 44726359)
24. Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 3:637-658, 2008.
25. Klimathianaki M, Vaporidi K, Georgopoulos D. Respiratory muscle dysfunction in COPD: from muscles to cell. Curr Drug Targets 12:478-488, 2011.
26. Levine S, Biswas C, Dierov J, Barsotti R, Shrager JB, Nguyen T, Sonnad S, Kucharchzuk JC, Kaiser LR, Singhal S, Budak MT. Increased proteolysis, myosin depletion, and atrophic AKT-FOXO signaling in human diaphragm disuse. Am J Respir Crit Care Med 183:483-490, 2011.
27. Levine S, Gregory C, Nguyen T, Shrager J, Kaiser L, Rubinstein N, Dudley G. Bioenergetic adaptation of individual human diaphragmatic myofibers to severe COPD. J Appl Physiol 92:1205-1213, 2002. (Pubitemid 34670981)
28. Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 337:1799-1806, 1997. (Pubitemid 28006784)
29. Levine S, Nguyen T, Kaiser LR, Rubinstein NA, Maislin G, Gregory C, Rome LC, Dudley GA, Sieck GC, Shrager JB. Human diaphragm remodeling associated with chronic obstructive pulmonary disease: clinical implications. Am J Respir Crit Care Med 168:706-713, 2003. (Pubitemid 37175973)
30. Levine S, Nguyen T, Shrager J, Kaiser L, Camasamudram V, Rubinstein N. Diaphragm adaptations elicited by severe chronic obstructive pulmonary disease: lessons for sports science. Exerc Sport Sci Rev 29:71-75, 2001. (Pubitemid 33691242)
31. Lieber R. Skeletal Muscle Structure, Function, and Plasticity. Baltimore, MD: Lippincott, Williams & Wilkins, 2002, p. 369.
32. Liu Y, Shen T, Randall WR, Schneider MF. Signaling pathways in activity-dependent fiber type plasticity in adult skeletal muscle. J Muscle Res Cell Motil 26:13-21, 2005. (Pubitemid 41531495)
33. Lokireddy S, McFarlane C, Ge X, Zhang H, Sze SK, Sharma M, Kambadur R. Myostatin induces degradation of sarcomeric proteins through a Smad3 signaling mechanism during skeletal muscle wasting. Mol Endocrinol 25:1936-1949, 2011.
34. Maltais F, Le Blanc P, Whittom F, Simard C, Marquis K, Belanger M, Breton MJ, Jobin J. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 55:848-853, 2000.
35. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, Le Blanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 153:288-293, 1996. (Pubitemid 26026864)
36. Marin-Corral J, Minguella J, Ramirez-Sarmiento AL, Hussain SN, Gea J, Barreiro E. Oxidised proteins and superoxide anion production in the diaphragm of severe COPD patients. Eur Respir J 33:1309-1319, 2009.
37. Mattson JP, Poole DC. Pulmonary emphysema decreases hamster skeletal muscle oxidative enzyme capacity. J Appl Physiol 85:210-214, 1998. (Pubitemid 28334927)
38. Mattson JP, Sun J, Murray DM, Poole DC. Lipid peroxidation in the skeletal muscle of hamsters with emphysema. Pathophysiology 8:215-221, 2002. (Pubitemid 34597214)
39. McKenzie DK, Butler JE, Gandevia SC. Respiratory muscle function and activation in chronic obstructive pulmonary disease. J Appl Physiol 107:621-629, 2009.
40. Mercadier JJ, Schwartz K, Schiaffino S, Wisnewsky C, Ausoni S, Heimburger M, Marrash R, Pariente R, Aubier M. Myosin heavy chain gene expression changes in the diaphragm of patients with chronic lung hyperinflation. Am J Physiol Lung Cell Mol Physiol 274:L527-L534, 1998.
41. Miranda EF, Malaguti C, Corso SD. Peripheral muscle dysfunction in COPD: lower limbs versus upper limbs. J Bras Pneumol 37:380-388, 2011.
42. Montes De Oca M, Torres SH, Gonzalez Y, Romero E, Hernandez N, Mata A, Talamo C. Peripheral muscle composition and health status in patients with COPD. Respir Med 100:1800-1806, 2006. (Pubitemid 44283753)
43. Nguyen T, Rubinstein NA, Vijayasarathy C, Rome LC, Kaiser LR, Shrager JB, Levine S. Effect of chronic obstructive pulmonary disease on calcium pump ATPase expression in human diaphragm. J Appl Physiol 98:2004-2010, 2005. (Pubitemid 40726890)
44. Oliven A, Supinski GS, Kelsen SG. Functional adaptation of diaphragm to chronic hyperinflation in emphysematous hamsters. J Appl Physiol 60:225-231, 1986. (Pubitemid 16024037)
45. Orozco-Levi M, Gea J, Lloreta JL, Felez M, Minguella J, Serrano S, Broquetas JM. Subcellular adaptation of the human diaphragm in chronic obstructive pulmonary disease. Eur Respir J 13:371-378, 1999. (Pubitemid 29086836)
46. Orozco-Levi M, Lloreta J, Minguella J, Serrano S, Broquetas JM, Gea J. Injury of the human diaphragm associated with exertion and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1734-1739, 2001. (Pubitemid 33124167)
47. Ottenheijm CA, Heunks LM, Dekhuijzen RP. Diaphragm adaptations in patients with COPD. Respir Res 9:12, 2008.
48. Ottenheijm CA, Heunks LM, Hafmans T, Van Der Ven PF, Benoist C, Zhou H, Labeit S, Granzier HL, Dekhuijzen PN. Titin and diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:527-534, 2006.
49. Ottenheijm CA, Heunks LM, Li YP, Jin B, Minnaard R, Van Hees HW, Dekhuijzen PN. Activation of the ubiquitin-proteasome pathway in the diaphragm in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174:997-1002, 2006. (Pubitemid 44684448)
50. Ottenheijm CA, Heunks LM, Sieck GC, Zhan WZ, Jansen SM, Degens H, De Boo T, Dekhuijzen PN. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172:200-205, 2005. (Pubitemid 40981194)
51. Powers SK, Kavazis AN, De Ruisseau KC. Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 288:R337-R344, 2005. (Pubitemid 40129594)
52. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse muscle atrophy. J Appl Physiol 102:2389-2397, 2007. (Pubitemid 47080773)
53. Powers SK, Nelson WB, Hudson MB. Exercise-induced oxidative stress in humans: cause and consequences. Free Radic Biol Med 51:942-950, 2011.
54. Puente-Maestu L, Perez-Parra J, Godoy R, Moreno N, Tejedor A, Gonzalez-Aragoneses F, Bravo JL, Alvarez FV, Camano S, Agusti A. Abnormal mitochondrial function in locomotor and respiratory muscles of COPD patients. Eur Respir J 33:1045-1052, 2009.
55. Rasbach KA, Gupta RK, Ruas JL, Wu J, Naseri E, Estall JL, Spiegelman BM. PGC-1α regulates a HIF2α-dependent switch in skeletal muscle fiber types. Proc Natl Acad Sci USA 107:21866-21871, 2010.
56. Ribera F, N'Guessan B, Zoll J, Fortin D, Serrurier B, Mettauer B, Bigard X, Ventura-Clapier R, Lampert E. Mitochondrial electron transport chain function is enhanced in inspiratory muscles of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167:873-879, 2003. (Pubitemid 36801776)
57. Rochester DF. The respiratory muscles in COPD. State of the art. Chest 85:47S-50S, 1984. (Pubitemid 14119454)
58. Rodriguez DA, Kalko S, Puig-Vilanova E, Perez-Olabarria M, Falciani F, Gea J, Cascante M, Barreiro E, Roca J. Muscle and blood redox status after exercise training in severe COPD patients. Free Radic Biol Med 52:88-94, 2012.
59. Sanchez J, Bastien C, Medrano G, Riquet M, Derenne JP. Metabolic enzymatic activities in the diaphragm of normal men and patients with moderate chronic obstructive pulmonary disease. Bull Eur Physiopathol Respir 20:535-540, 1984. (Pubitemid 15221462)
60. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412, 2004. (Pubitemid 38534545)
61. Sauleda J, Garcia-Palmer F, Wiesner RJ, Tarraga S, Harting Tomas P, Gomez C, Saus C, Palou A, Agusti AG. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157:1413-1417, 1998.
62. Schols AM, Gosker HR. The pathophysiology of cachexia in chronic obstructive pulmonary disease. Curr Opin Support Palliat Care 3:282-287, 2009.
63. Scott A, Wang X, Road JD, Reid WD. Increased injury and intramuscular collagen of the diaphragm in COPD: autopsy observations. Eur Respir J 27:51-59, 2006. (Pubitemid 43092666)
64. Shi H, Scheffler JM, Pleitner JM, Zeng C, Park S, Hannon KM, Grant AL, Gerrard DE. Modulation of skeletal muscle fiber type by mitogenactivated protein kinase signaling. FASEB J 22:2990-3000, 2008.
65. Singh S, Harrison S, Houchen L, Wagg K. Exercise assessment and training in pulmonary rehabilitation for patients with COPD. Euro J Phys Rehab Med 47:483-497, 2011.
66. Supinski GS, Kelsen SG. Effect of elastase-induced emphysema on the force-generating ability of the diaphragm. J Clin Invest 70:978-988, 1982. (Pubitemid 13254921)
67. Szentesi P, Zaremba R, Van Mechelen W, Stienen GJ. ATP utilization for calcium uptake and force production in different types of human skeletal muscle fibres. J Physiol 531:393-403, 2001. (Pubitemid 32229665)
68. Testelmans D, Crul T, Maes K, Agten A, Crombach M, Decramer M, Gayan-Ramirez G. Atrophy and hypertrophy signalling in the diaphragm of patients with COPD. Eur Respir J 35:549-556, 2010.
69. Tonkin J, Villarroya F, Puri PL, Vinciguerra M. SIRT1 signaling as potential modulator of skeletal muscle diseases. Curr Opin Pharmacol 12:372-376, 2012.
70. Tothova J, Blaauw B, Pallafacchina G, Rudolf R, Argentini C, Reggiani C, Schiaffino S. NFATc1 nucleocytoplasmic shuttling is controlled by nerve activity in skeletal muscle. J Cell Sci 119:1604-1611, 2006. (Pubitemid 43732986)
71. Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ. Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296:C1258-C1270, 2009.
72. Vogiatzis I, Simoes DC, Stratakos G, Kourepini E, Terzis G, Manta P, Athanasopoulos D, Roussos C, Wagner PD, Zakynthinos S. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J 36:301-310, 2010.
73. Vogiatzis I, Terzis G, Stratakos G, Cherouveim E, Athanasopoulos D, Spetsioti S, Nasis I, Manta P, Roussos C, Zakynthinos S. Effect of pulmonary rehabilitation on peripheral muscle fiber remodeling in patients with COPD in GOLD stages II to IV. Chest 140:744-752, 2011.
74. Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J 31:492-501, 2008.
75. Wagner PD. Skeletal muscles in chronic obstructive pulmonary disease: deconditioning, or myopathy? Respirology 11:681-686, 2006. (Pubitemid 44581430)
76. Wagner PD. Vascular endothelial growth factor and the pathogenesis of emphysema. Am J Med 114:413-414, 2003. (Pubitemid 36513693)
77. Watchko JF, Sieck GC. Respiratory muscle fatigue resistance relates to myosin phenotype and SDH activity during development. J Appl Physiol 75:1341-1347, 1993. (Pubitemid 23289629)
78. White AT, Schenk S. NAD+/NADH and skeletal muscle mitochondrial adaptations to exercise. Am J Physiol Endocrinol Metab 303:E308-E321, 2012.
79. Wijnhoven JH, Janssen AJ, Van Kuppevelt TH, Rodenburg RJ, Dekhuijzen PN. Metabolic capacity of the diaphragm in patients with COPD. Respir Med 100:1064-1071, 2006.
80. Zanini A, Chetta A. Vascular endothelial growth factor in the human diaphragm: new insight into adaptation mechanisms in chronic obstructive pulmonary disease patients. Respiration 72:577-578, 2005. (Pubitemid 41798134)